ULBI - Ultralife Corporation

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 67.77M
Enterprise value 85.29M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.51
Price/book (mrq)0.58
Enterprise value/revenue 0.64
Enterprise value/EBITDA 105.43

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3-11.80%
S&P500 52-week change 31.77%
52-week high 35.7700
52-week low 33.6700
50-day moving average 34.0824
200-day moving average 34.3840

Share statistics

Avg vol (3-month) 317.98k
Avg vol (10-day) 311.46k
Shares outstanding 516.14M
Implied shares outstanding 6N/A
Float 89.97M
% held by insiders 16.82%
% held by institutions 163.25%
Shares short (14 May 2023) 424.35k
Short ratio (14 May 2023) 41.81
Short % of float (14 May 2023) 40.70%
Short % of shares outstanding (14 May 2023) 40.15%
Shares short (prior month 13 Apr 2023) 424.38k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin -0.22%
Operating margin (ttm)0.96%

Management effectiveness

Return on assets (ttm)0.48%
Return on equity (ttm)-0.25%

Income statement

Revenue (ttm)133.38M
Revenue per share (ttm)8.27
Quarterly revenue growth (yoy)5.10%
Gross profit (ttm)29.4M
Net income avi to common (ttm)-297k
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.61M
Total cash per share (mrq)0.35
Total debt (mrq)25.16M
Total debt/equity (mrq)21.62
Current ratio (mrq)2.79
Book value per share (mrq)7.21

Cash flow statement

Operating cash flow (ttm)594k
Levered free cash flow (ttm)-229.12k